Preliminary Study for the Protein C Purification Using Mini-Antibodies Produced from Recombinant E. coli

  • Lino K. Korah
  • Kyung A. Kang
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 540)


Protein C (PC) is an anticoagulant, antithrombotic, and anti-inflammatory protein in the blood. PC deficiency can lead to blood clots and these clots can prevent the nutrient and oxygen from being transported to tissues. In addition, blood clots detached from the origin can lead to pulmonary embolism, heart attack, and stroke. Purified PC has valuable therapeutic functions for PC-deficient patients, sepsis patients1, and patients undergoing major surgeries2,3. The current purification method for PC is expensive due to the high cost of monoclonal antibodies (by animal cell culture) used as a ligand in immunoaffinity chromatography separation3. In an attempt to lower the PC purification cost, a cheaper ligand, the single chain variable fragment (ScFv; mini-Ab) produced by recombinant E. coli is currently being studied.


Immobilize Metal Affinity Chromatography Purification Efficiency Animal Cell Culture Single Chain Variable Fragment Adsorption Stage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Eli Lilly (Indiana, August, 2001);
  2. 2.
    Kang, K.A., Ryu, D., Drohan, W.M., and Orthner, C.L., Effect of matrices on affinity purification of protein C, Biotechnol Bioeng. 39, 1086–1096 (1992).PubMedCrossRefGoogle Scholar
  3. 3.
    Korah, L.K., Ahn, D.G., an Kang, K.A., Development of an economic miniantibody production process for the purification of Protein C (anti-coagulant/anti-thrombotic), Proceedings of the Annual 2001 ISOTT meeting [In Press].Google Scholar
  4. 4.
    Wu, H., Goud, G.N. and Sierks, M.R., Artificial antibodies for affinity chromatography of homologous proteins: application to blood proteins, Biotechnol. Progr. 14, 496–499 (1998).CrossRefGoogle Scholar
  5. 5.
    Wilkinson, D., Immunochemical techniques inspire development of new antibody purification methods, Scientist 14 (8), 25 (2000).Google Scholar
  6. 6.
    Amersham Biosciences (New Jersey, August 1, 2002); Scholar
  7. 7.
    Laemmli, U.K., Clevage of structural proteins during the assembly of the head of the bacteriophage T4, Nature 227, 680–685 (1970).PubMedCrossRefGoogle Scholar
  8. 8.
    Akestrom, B. Nilson, B.H.K., Hoogenboon, H.R., and Bjorck, L., On the interaction between single chain Fv antibodies and bacterial immunoglobulins-binding proteins, J. Immunol. Methods 177, 151–163 (1994).Google Scholar
  9. 9.
    Griffiths,A.D., Williams, S.C., Hartlet, O., Tomlinson, I.M., Waterhouse, P., Crosby, W.L., Kontermann, R.E., Jones, P.T., Low, N.L., Allison, J., Prospero, T.D., Hoogenboom, H.R., Nissim, A., Cox, J.P.L., Harrison, J.L., Zaccolo, M., Gherardi, E., and Winter, G., Isolation of high affinity human antibodies directly from large synthetic repertories, EMBO Journal 13 (14), 3245–3260 (1994).Google Scholar
  10. 10.
    Center for Protein Engineering, (Cambridge, August 1, 2002); Scholar
  11. 11.
    Luo, Q., Zou, H., Xiao, X., Guo, Z., Kong, L., and, Mao, X., Chromatographic separation of proteins on metal immobilized iminodiacetic acid-bound molded monolithic rods of macroporous poly (glycidyl methacrylate-co-ethylene dimetharylate), J. Chromatogr. A 926, 255–264 (2001).PubMedCrossRefGoogle Scholar
  12. 12.
    Sterogene (California, August 1, 2002);

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Lino K. Korah
    • 1
  • Kyung A. Kang
    • 1
  1. 1.University of LouisvilleLouisvilleUSA

Personalised recommendations